🔥🐔 BizChicken 🐔🔥
Companies Similar to Revolution Medicines, Inc.
Sign Up Today!
Sign up for BizChicken and discover more about the corporations around you.
ORIC Pharmaceuticals, Inc.
ORIC-533, ORIC-944, ORIC-114
ORIC Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company that discovers and develops therapies for the treatment of cancers, focusing on overcoming resistance in chemotherapy and immunotherapy. Their product candidates target various cancer resistance mechanisms, including prostate cancer and epidermal growth factor receptor mutations.
Symbol: ORIC
Recent Price: $8.17
Industry: Biotechnology
CEO: Dr. Jacob M. Chacko M.B.A., M.D.
Sector: Healthcare
Employees: 107
Address: 240 East Grand Avenue, South San Francisco, CA 94080
Phone: 650 388 5600
Last updated: 2024-12-31
Replimune Group, Inc.
RP1
Replimune Group, Inc. develops oncolytic immuno-gene therapies to treat cancer using its proprietary Immunotherapy platform. Its lead product, RP1, is in clinical trials for treating solid tumors.
Symbol: REPL
Recent Price: $12.33
Industry: Biotechnology
CEO: Dr. Sushil Patel Ph.D.
Sector: Healthcare
Employees: 331
Address: 500 Unicorn Park Drive, Woburn, MA 01801
Phone: 781 222 9600
Last updated: 2024-12-31
Revelation Biosciences, Inc.
REVTx-99b
Revelation Biosciences, Inc. is a clinical-stage biopharmaceutical company focused on developing and commercializing immune system therapeutics and diagnostics, including products for chronic nasal congestion, allergic rhinitis, chronic organ disease, and viral infections.
Symbol: REVB
Recent Price: $0.39
Industry: Biotechnology
CEO: Mr. James M. Rolke
Sector: Healthcare
Employees: 9
Address: 4660 La Jolla Village Drive, San Diego, CA 92122
Phone: 650-800-3717
Last updated: 2024-12-31
Reneo Pharmaceuticals, Inc.
REN001
Reneo Pharmaceuticals, Inc., a clinical-stage pharmaceutical company, focuses on developing therapies for patients with rare genetic mitochondrial diseases. Its primary product, REN001, is a selective peroxisome proliferator-activated receptor delta agonist currently in clinical trials.
About | About | About | Management | Directors | Contact | Contact | Careers | Careers | About | About | About
Symbol: RPHM
Recent Price: $18.20
Industry: Biotechnology
CEO: Mr. Gregory J. Flesher
Sector: Healthcare
Employees: 8
Address: 18575 Jamboree Road, Irvine, CA 92612
Phone: 619 733 3852
Last updated: 2024-12-31
Reviva Pharmaceuticals Holdings, Inc.
RP5063
Reviva Pharmaceuticals Holdings, Inc. is a clinical-stage biopharmaceutical company focused on discovering, developing, and commercializing next-generation therapeutics for unmet medical needs, particularly in central nervous system, respiratory, cardiovascular, metabolic, and inflammatory diseases.
Symbol: RVPH
Recent Price: $1.81
Industry: Biotechnology
CEO: Dr. Laxminarayan Bhat Ph.D.
Sector: Healthcare
Employees: 15
Address: 19925 Stevens Creek Boulevard, Cupertino, CA 95014
Phone: 408 501 8881
Last updated: 2024-12-31
Acrivon Therapeutics, Inc. Common Stock
Acrivon Predictive Precision Proteomics
Acrivon Therapeutics is a clinical stage biopharmaceutical company developing oncology medicines using a proteomics-based platform to identify patient responders. Their lead candidate, ACR-368, is in Phase 2 trials for various cancers.
Symbol: ACRV
Recent Price: $5.41
Industry: Biotechnology
CEO: Dr. Peter Blume-Jensen M.D., Ph.D.
Sector: Healthcare
Employees: 58
Address: 480 Arsenal Way, Watertown, MA 02472
Phone: 617-207-8979
Last updated: 2024-12-31
Compass Therapeutics, Inc.
CTX-009, CTX-471, CTX-8371
Compass Therapeutics, Inc. is a clinical-stage oncology-focused biopharmaceutical company developing antibody-based therapeutics to treat various human diseases. Their clinical stage products include investigational bispecific antibodies like CTX-009 and monoclonal antibodies such as CTX-471.
Symbol: CMPX
Recent Price: $1.48
Industry: Biotechnology
CEO: Dr. Thomas J. Schuetz M.D., Ph.D.
Sector: Healthcare
Employees: 32
Address: 80 Guest Street, Boston, MA 02135
Phone: 617 500 8099
Last updated: 2024-12-31
FibroGen, Inc.
Roxadustat, Pamrevlumab
Fibro Gen, Inc. is a biopharmaceutical company focused on discovering, developing, and commercializing therapeutics to treat serious unmet medical needs, including treatments for anemia, idiopathic pulmonary fibrosis, and Duchenne muscular dystrophy.
Symbol: FGEN
Recent Price: $0.53
Industry: Biotechnology
CEO: Mr. Thane Wettig
Sector: Healthcare
Employees: 486
Address: 409 Illinois Street, San Francisco, CA 94158
Phone: 415 978 1200
Last updated: 2024-12-31
Moderna, Inc.
messenger RNA therapeutics and vaccines
Moderna, Inc. is a biotechnology company specializing in the discovery, development, and commercialization of messenger RNA therapeutics and vaccines for various diseases including infectious diseases and cancer. It operates globally with a range of vaccines targeting respiratory, latent, and public health viruses.
Vision/Values | Contact | Careers | Careers | Careers | Careers | About | Careers | About | About | About | About | About | About | About | About | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Awards | Careers | Careers | Careers | Careers | Careers | Careers | About | About | About | About | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Awards | Awards | Awards | Awards | Awards | Awards | Awards | Awards | Awards | Awards | Awards | Awards | Awards | Awards | Awards | Awards | Awards | Awards | Awards | Awards | Awards | Awards | Careers | Careers | About | About | About | About | About | News | About
Symbol: MRNA
Recent Price: $39.38
Industry: Biotechnology
CEO: Mr. Stephane Bancel
Sector: Healthcare
Employees: 5600
Address: 200 Technology Square, Cambridge, MA 02139
Phone: 617 714 6500
Last updated: 2024-12-31
PMV Pharmaceuticals, Inc.
PC14586
PMV Pharmaceuticals, Inc. is a precision oncology company focused on the discovery and development of small molecule and tumor-agnostic therapies targeting p53 mutations in cancer, including lead product candidate PC14586.
Symbol: PMVP
Recent Price: $1.49
Industry: Biotechnology
CEO: Dr. David H. Mack Ph.D.
Sector: Healthcare
Employees: 63
Address: 8 Clarke Drive, Cranbury, NJ 08512
Phone: 609 642 6670
Last updated: 2024-12-31
Rocket Pharmaceuticals, Inc.
Gene Therapies
Rocket Pharmaceuticals, Inc. is a biotechnology company focused on developing gene therapies for rare and devastating diseases, with multiple clinical-stage programs targeting disorders such as fanconi anemia, leukocyte adhesion deficiency-I, pyruvate kinase deficiency, and Danon disease.
Symbol: RCKT
Recent Price: $12.03
Industry: Biotechnology
CEO: Dr. Gaurav D. Shah M.D.
Sector: Healthcare
Employees: 268
Address: 9 Cedarbrook Drive, Cranbury, NJ 08512
Phone: 609 659 8001
Last updated: 2024-12-31
Relay Therapeutics, Inc.
RLY-4008, RLY-2608, RLY-1971
Relay Therapeutics, Inc. is a clinical-stage company that focuses on precision medicine in oncology and genetic diseases by transforming the drug discovery process. Their leading products include small molecule inhibitors for advanced cancer treatment.
Symbol: RLAY
Recent Price: $4.18
Industry: Biotechnology
CEO: Dr. Sanjiv K. Patel M.A., M.B.A., M.D., MBBS
Sector: Healthcare
Employees: 323
Address: 399 Binney Street, Cambridge, MA 02139
Phone: 617 370 8837
Last updated: 2024-12-31
TransCode Therapeutics, Inc.
TTX-MC138
Trans Code Therapeutics, Inc. is a biopharmaceutical company focused on developing and commercializing drugs and diagnostics for treating metastatic disease. Their lead product, TTX-MC138, is aimed at metastatic cancer treatment, along with a range of other therapeutic platforms targeting cancer through innovative RNA- and CRISPR-based technologies.
Symbol: RNAZ
Recent Price: $3.76
Industry: Biotechnology
CEO: Mr. Thomas A. Fitzgerald M.B.A.
Sector: Healthcare
Employees: 10
Address: 6 Liberty Square, Boston, MA 02109
Phone: 857-837-3099
Last updated: 2024-12-31
RenovoRx, Inc.
Renovo Gem
Renovo Rx, Inc. is a clinical-stage biopharmaceutical company focusing on developing therapies for the treatment of solid tumors, with its lead product candidate, Renovo Gem, in Phase III clinical trials for locally advanced pancreatic cancer.
Leadership | Directors | About | Contact | Careers | Careers | Jobs | Careers | Careers | Jobs | Careers | Careers | About | About | About | About | About | About
Symbol: RNXT
Recent Price: $1.39
Industry: Biotechnology
CEO: Mr. Shaun R. Bagai
Sector: Healthcare
Employees: 8
Address: 4546 El Camino Real, Los Altos, CA 94022
Phone: 650 284 4433
Leadership
- Shaun R. Bagai, Director and Chief Executive Officer
- Ramtin Agah, MD, Chairman, Chief Medical Officer, and Founder
- Leesa Gentry, Chief Clinical Officer
- Ronald B. Kocak, CPA, VP Controller and Principal Accounting Officer
- Ryan Witt, Senior Vice President, Head of Corporate Strategy and Partnerships
- Imtiaz Qureshi, MD, Director of Imaging
- Angela Macfarlane, CEO of Perceive Biotherapeutics, Inc.
- Laurence J. Marton, MD, Director
- Una S. Ryan, PhD, OBE, Director
- Robert J. Spiegel, Director
Last updated: 2024-12-31
Revolution Medicines, Inc.
RMC-4630
Revolution Medicines, Inc. is a clinical-stage precision oncology company focused on developing therapies targeting frontier targets in RAS-addicted cancers.
Symbol: RVMD
Recent Price: $43.17
Industry: Biotechnology
CEO: Dr. Mark A. Goldsmith Ph.D.
Sector: Healthcare
Employees: 378
Address: 700 Saginaw Drive, Redwood City, CA 94063
Phone: 650 481 6801
Last updated: 2024-12-31
Recursion Pharmaceuticals, Inc.
REC-994
Recursion Pharmaceuticals is a clinical-stage biotechnology company focusing on decoding biology to industrialize drug discovery, integrating technological innovations across multiple disciplines.
Symbol: RXRX
Recent Price: $6.77
Industry: Biotechnology
CEO: Dr. Christopher C. Gibson Ph.D.
Sector: Healthcare
Employees: 500
Address: 41 South Rio Grande Street, Salt Lake City, UT 84101
Phone: 385 269 0203
Last updated: 2024-12-31
Rhythm Pharmaceuticals, Inc.
IMCIVREE
Rhythm Pharmaceuticals, Inc. is a commercial-stage biopharmaceutical company dedicated to developing and commercializing treatments for rare genetic diseases of obesity. Their lead product, IMCIVREE, targets specific genetic disorders causing obesity, and they are also advancing other therapeutic candidates through clinical trials.
Contact | Contact | Contact | News | News | About | About | Jobs | About | About | Careers | About
Symbol: RYTM
Recent Price: $56.34
Industry: Biotechnology
CEO: Dr. David P. Meeker M.D.
Sector: Healthcare
Employees: 226
Address: 222 Berkeley Street, Boston, MA 02116
Phone: 857 264 4280
Last updated: 2024-12-31
TRACON Pharmaceuticals, Inc.
therapeutics for cancer
TRACON Pharmaceuticals is a biopharmaceutical company focused on developing and commercializing cancer therapeutics, including clinical stage products like envafolimab, YH001, TRC102, and TJ004309, with collaboration agreements with various biopharmaceutical companies.
Symbol: TCON
Recent Price: $0.03
Industry: Biotechnology
CEO: Mr. Craig R. Jalbert CIRA
Sector: Healthcare
Employees: 17
Address: 4350 La Jolla Village Drive, San Diego, CA 92122
Phone: 858 550 0780
Last updated: 2024-12-31
Verve Therapeutics, Inc.
VERVE-101
Verve Therapeutics, Inc. is a genetic medicines company developing gene editing treatments for cardiovascular diseases, primarily through its lead product VERVE-101.
Symbol: VERV
Recent Price: $5.54
Industry: Biotechnology
CEO: Dr. Sekar Kathiresan M.D.
Sector: Healthcare
Employees: 255
Address: 500 Technology Square, Cambridge, MA 02139
Phone: 617 603 0070
Leadership
- Andrew Ashe, President, Chief Operating Officer and General Counsel
- Victoria Bartlett, Vice President, Program and Alliance Management
- Dan Balian, Associate Director, Supply Chain Management
- Allen Barrett, Director, Corporate Counsel
Last updated: 2024-12-31
Marker Therapeutics, Inc.
Multi TAA-specific T cell technology
Marker Therapeutics, Inc. is a clinical-stage immuno-oncology company developing T cell-based immunotherapies and peptide-based vaccines for treating hematological malignancies and solid tumors in the US.
Contact | About | Management | Directors | About | Contact | Contact | Careers | About | About
Symbol: MRKR
Recent Price: $3.34
Industry: Biotechnology
CEO: Dr. Juan F. Vera M.D.
Sector: Healthcare
Employees: 8
Address: 3200 Southwest Freeway, Houston, TX 77027
Phone: 713 400 6400
Leadership
- David Eansor, President, Protein Sciences Segment, Bio-Techne Corporation
- Steve Elms, Managing Partner, Aisling Capital
- John R. Wilson, CEO, Wilson Wolf Manufacturing, Co-Founder Marker Therapeutics, Co-Founder AlloVir
- Juan F. Vera, Chief Executive Officer & Co-Founder, Marker Therapeutics, Co-Founder, AlloVir
- Katharine Knobil, M.D., Chief Medical Officer at Agilent Technologies, Inc.
Last updated: 2024-12-31